2018 American Transplant Congress » Poster Session D: Kidney Infectious

6:00pm-7:00pm

Assessment of Methenamine Hippurate for the Prevention of Recurrent Urinary Tract Infections in Adult Renal Transplant Recipients: A Single Center, Retrospective Study

I. Hollyer,¹ F. Varias,³ B. Ho,¹ M. Ison.¹

6:00pm-7:00pm

Association of Immunosuppressive Therapy Regimen with Sepsis Outcomes among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹

6:00pm-7:00pm

BK Nephropathy in Non-Kidney Transplant Patients, a Case Series and Systematic Review of the Literature

A. Shah,¹ V. Kumar,² B. Laskin,^2,3 D. Sawinski,^1,2 J. Hogan.^1,2

6:00pm-7:00pm

CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients

H. Pizzo, B. Shin, M. Toyoda, S. Jordan, D. Puliyanda.

6:00pm-7:00pm

Clinical Outcomes of HIV-Infected Kidney Transplant Recipients Managed with an Early Corticosteroid Withdrawal Protocol

A. Al Jurdi, E. Liu, M. Aull, M. Lubetsky, D. Serur, S. Kapur, T. Muthukumar.

6:00pm-7:00pm

Decision-Making, Informed Consent, and the Experiences of Recipients of Experimental HCV Positive-to-Negative Renal Transplants

S. Rasmussen, S. Seaman, D. Brown, N. Desai, M. Sulkowski, D. Segev, J. Sugarman, C. Durand.

6:00pm-7:00pm

Early versus Late Cytomegalovirus Prophylaxis after Kidney Transplant

M. Harris, J. Byrns, J. Gommer, M. Laub, M. Ellis.

6:00pm-7:00pm

Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient

P. Brown, D. Venkat.

6:00pm-7:00pm

Having Your Cake and Eating It Too: An Aggressive Protocol for DSA Treatment Does Not Doom Patients to High Infectious Risk

A. Murthy, A. Karaballa, G. Vranic, B. Javaid, J. Moore, S. Yi, J. Verbesey, P. Abrams, S. Ghasemian, M. Cooper, A. Gilbert.

6:00pm-7:00pm

Impact of Direct Antiviral Therapy for Hepatitis C on Acute Rejection and DSA Formation in Kidney Transplant Recipients

Z. Zaky, S. Armanyous, L. Herlitz, E. Poggio, J. Augustine.

6:00pm-7:00pm

Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation

M. Campara, P. West-Thielke, K. Progar, N. Jasiak, A. Lichvar, I. Tang, E. Benedetti.

6:00pm-7:00pm

Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests

V. Garcia, G. Meinerz, C. da Silva, E. Keitel.

6:00pm-7:00pm

Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant

G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.

6:00pm-7:00pm

Multi-Drug Resistant Urinary Tract Infections Following Renal Transplant: Risk Factors and Patient Outcomes

D. Hooker,¹ K. Gutierrez,² K. Foster,¹ A. Dodson.²

6:00pm-7:00pm

One-Year Outcomes in Patients with Advanced Liver Fibrosis or Compensated Cirrhosis from Chronic Hepatitis C Receiving Kidney Transplant Alone

P. Brown, F. Kumssa, D. Venkat.

6:00pm-7:00pm

Oral Vancomycin Monotherapy versus Combination Therapy in Solid Organ Transplant Recipients with Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study

G. Korayem,^1,2,4 K. Eljaaly,^2,3 K. Matthias,^2,4 T. Zangeneh.^4,5

6:00pm-7:00pm

Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol

P. West-Thielke, M. Campara, I. Tang, E. Benedetti.

6:00pm-7:00pm

Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

L. Chen,¹ D. Kamiyama,² L. Francalacci,¹ E. Zhu,² M. Donnelley,² N. Clayton,² K. Alman,¹ A. De Mattos,¹ J. Brown.³

6:00pm-7:00pm

Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes

S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.

6:00pm-7:00pm

Safety and Efficacy of Sofosbuvir-Based Direct-Acting Antiviral Agents in Kidney Transplant Recipients with HCV: A Systematic Review and Meta-Analysis

X. Wang,¹ P. Tan,¹ T. Xiang,² Y. Qiu,¹ T. Song,¹ T. Lin.¹

6:00pm-7:00pm

Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients

J. Mittal, J. Mogollon, K. Cowman, P. Nori, V. Muggia, G. Minamoto, Y. Puius.

6:00pm-7:00pm

Ten Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients

S. El Hajj, J. Azzi, M. Kim, S. Gabardi.

6:00pm-7:00pm

The Impact of Induction Agent on Development of Febrile Neutropenia Following Kidney Transplant

G. Dube, S. Husain, D. Cohen, S. Mohan.

6:00pm-7:00pm

The Role of Pre-Emptive Antibiotic Therapy in Kidney Recipients of Donors with Urine-Only Positive Cultures

P. Cabrera,¹ A. Centeno,¹ J. Revollo,¹ J. Camargo.²

6:00pm-7:00pm

Treatment of HCV Infection in Renal Transplant Recipients

M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.

6:00pm-7:00pm

Urinary Tract Infections May Be Associated with De Novo Donor-Specific Anti-Human Leucocyte Antigen Antibodies: Single-Center Study

M. Everly,¹ A. Babu,¹ K. Briley,² P. Bolin,² S. Kendrick,³ H. Jones,³ K. McLawhorn,³ A. Maldonado,⁴ C. Haisch,² D. Leeser,² L. Rebellato.²

6:00pm-7:00pm

Use of Granulocyte Colony-Stimulating Factor for Leukopenia Post-Renal Transplant

S. Hamel,¹ V. Kuo,² D. Johnson,¹ R. Bloom,³ D. Sawinski,³ J. Trofe-Clark.^1,3

6:00pm-7:00pm

Val-Ganciclovir Prophylaxis Delays Onset of EBV Viremia in the First Year Post-Solid Organ Transplantation in High-Risk Patients

S. Albatati,¹ A. Sharma,² S. Gantt,¹ K. Haubrich,¹ A. Wright,¹ T. Blydt-Hansen.¹